Grimes & Company’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Sell
1,266
-113
-8% -$32.6K 0.01% 359
2026
Q1
$433K Buy
1,379
+40
+3% +$14K 0.01% 315
2025
Q4
$452K Buy
1,339
+45
+3% +$15.3K 0.01% 322
2025
Q3
$405K Buy
1,294
+22
+2% +$6.47K 0.01% 336
2025
Q2
$381K Buy
1,272
+44
+4% +$12.7K 0.01% 301
2025
Q1
$342K Buy
1,228
+2
+0.2% +$502 0.01% 280
2024
Q4
$275K Buy
1,226
+19
+2% +$4.47K 0.01% 320
2024
Q3
$272K Sell
1,207
-22
-2% -$5.11K 0.01% 308
2024
Q2
$277K Buy
1,229
+32
+3% +$7.41K 0.01% 278
2024
Q1
$291K Buy
1,197
+2
+0.2% +$460 0.01% 274
2023
Q4
$246K Sell
1,195
-9
-0.7% -$1.76K 0.01% 280
2023
Q3
$217K Buy
1,204
+3
+0.2% +$554 0.01% 269
2023
Q2
$231K Buy
+1,201
New +$208K 0.01% 268

Other funds holding COR

Grimes & Company's COR Position: Q2 2026 in Review

Grimes & Company reduced its Cencora (COR) stake by 8.2% in Q2 2026, selling an estimated $32.6K and leaving 1,266 shares worth $358K. The position accounts for 0.01% of the portfolio, ranked #359.

Grimes & Company first reported a position in COR in Q2 2023 and has held it in 13 quarters since. The position peaked at $452K in Q4 2025. 337 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • Grimes & Company held 1,266 shares of Cencora worth $358K as of Q2 2026.
  • Grimes & Company sold 113 Cencora shares in Q2 2026, an estimated $32.6K.
  • Cencora made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #359 holding.
  • Grimes & Company first reported a position in Cencora in Q2 2023 and has held it in 13 quarters since.
  • Grimes & Company's Cencora position peaked at $452K in Q4 2025.
  • 337 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.